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EFFECT OF CHLOROGENIC ACID AND NEOCHLOROGENIC
ACID ON HUMAN COLON CANCER CELLS
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ABSTRACT

Prune consumption has been associated with a decreased risk of colon cancer, yet there
has been confusion as to which chemical component(s) of the prune are responsible for
its anticarcinogenic properties. Previous studies have evaluated chlorogenic acid as a
chemotherapeutic agent, however only a limited amount of studies have investigated
neochlorogenic acid, the predominant phenolic compound found in the prune.

The

purpose of this study was to determine the effects that chlorogenic acid and
neochlorogenic acid have as anticarcinogenics on the human adenocarcinoma, Caco-2
cell line. The anti-colon cancer effects or chlorogenic acid and neochlorogenic acid were
analyzed by experiments that measured cell proliferation and morphology in culture of
Caco-2 cells.

Treatment of cells with chlorogenic acid and neochlorogenic acid

significantly reduced cell proliferation at concentrations of 150-500µmol at 24, 48, and
72 hours by 63.7-96.0% and 69.7-94.2%, respectively (p<0.05). At the majority of
sample times and concentrations, chlorogenic acid and neochlorogenic acid did not
significantly differ in percent reduction of viable cells (p<0.05). The cell morphology of
treated cells changed, as the surface of cells became more rough, uneven, and irregularlyshaped as the concentration of the treatment increased, compared to the untreated Caco-2
cell.

These findings of significant cell proliferation inhibition suggest that both

chlorogenic acid and neochlorogenic acid could be colon cancer suppressive components
of the prune.
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Chapter I. Introduction
Colorectal cancer is the second leading cause of cancer-related deaths in the
United States. Based on the rates from 2005-2009, 54.0 men and 40.2 women out of
100,000 in the United States will be diagnosed with colorectal cancer each year. For
future generations, this means 4.96% men and women born today will be diagnosed with
cancer of the colon and rectum during their lifetimes. Although incidence and mortality
rates have declined since 1998, colorectal cancer is still an imminent threat. Locally,
trends for colorectal cancer are still unfavorable. Arkansas is well above the U.S. death
rate for cancer of the colon and rectum in both men and women, having an annual death
rate of 18.9 deaths per 100,000, compared to the national average of 17.1 per 100,000.
Risk factors associated with colorectal cancer include increasing age, race, sex, heredity,
preexisting conditions, tobacco usage and diet (1).
It is estimated that 30-60% of cancers may be diet-related. Thus, alterations of
the diet to include whole-grain cereals, fruits and vegetables could provide protection
from diet-related cancers. Consumption of these protective foods could prevent up to 6675% of colon cancers (2).
The prune is linked to decreased risk of colon cancer and is rich in phenolic
antioxidants that may be responsible for this anticarcinogenic behavior.

Of all the

phenolic compounds present in the prune, neochlorogenic acid is the most predominant,
followed by chlorogenic acid (3). The goal of this study is to determine the effects of
chlorogenic acid and neochlorogenic acid on human colon cancer cells. The hypothesis
of this study is that one or more of the chlorogenic acid and neochlorogenic acid
treatment concentrations tested will be able to effectively inhibit colon cancer cell
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proliferation. The objectives of this study were to: 1) determine if chlorogenic acid and
neochlorogenic acid can effectively inhibit colon cancer cell proliferation, 2) determine
what concentrations of chlorogenic acid and neochlorogenic acid are effective at
inhibiting cell growth, and 3) establish the time requirement to significantly reduce the
number of viable cells. To achieve these objectives, cell viability was measured and cell
morphology was observed.
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Chapter II. Literature Review
Colon Cancer
Cancer is the leading cause of death worldwide, and was responsible for 7.6
million deaths in 2008. According to the World Health Organization (WHO), 608,000 of
these cancer related deaths were due to colorectal cancer.

Colorectal cancer is the

seconding leading cause of cancer-related deaths in the United States in both men and
women. In 2012, it is estimated that there will be more than 143,000 people diagnosed
with CRC, and approximately 52,000 deaths due to CRC. This would make CRC the
fourth most common cancer in men, after skin, prostate, and lung cancer, and the fourth
most common cancer in women, after skin, breast, and lung cancer. Based on rates from
2006-2008, 1 in 20 men and women born today will be diagnosed with colorectal cancer
at some point in their lifetime. The risk factors associated with CRC include increasing
age, family history of CRC, genetic alterations, tobacco usage, and diet. The colon’s
function of absorbing water and nutrients from food support the strong correlation
between diet and colorectal cancer. Diets high in fat and low in calcium, folate, and fiber
are associated with a higher risk of CRC. A diet low in fruits and vegetables also suggest
a higher risk of CRC. Due to the epidemiological studies that suggest a relationship
between a diet high in fruits and vegetables and lower rates of cancers in the esophagus,
prostate, colon, and stomach; the phenolic compounds found in fruits are of great interest
because of their potential anticarcinogenic properties. It has been suggested that phenolic
compounds, such as the hydroxycinnamic acids, chlorogenic acid and neochlorogenic
acids in the prune, are responsible for the inverse association between fruit consumption
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and cancer. This review will focus on two of the phenolic compounds found in the
prune: neochlorogenic acid and chlorogenic acid.
Colorectal cancer (CRC) occurs in the tissue of the colon, the first four to five feet
of the large intestine, and in the rectum, which is the passageway that connects the colon
to the anus. Most cases of CRC are found in the form of an adenocarcinoma, meaning
that the cancer begins in cells that make and release mucus and other fluids. Colorectal
cancer affects both men and women and is seen in all racial and ethnic groups, but found
most significantly in people 50 years of age and older. CRC is responsible for substantial
medical and societal costs, with an estimated direct medical cost of $14 billion in 2010
(1).

General Information of Prune/Plum
Plums are the fruits of Prunus in the Rosaceae family (4). The drying of plums
will yield dried plums, otherwise known as prunes. The majority of prunes are the dried
fruits of cultivars of Prunus domestica L., which originated from the Caucasus region in
Eurasia (5). Prunes are the byproduct of crossbreeding a cherry plum and a tetraploid
blackthorn (3). Currently, plums are produced to become whole canned plums, prunes,
prune juice, pastes, sauces, juice concentrates, and prune bits (6). A recent interest has
been taken in prunes due to having the best nutrient score among dried fruits, along with
figs (7). For these reasons and more, dried plums have recently been promoted as a
health food (8). However, since edible plants are not considered to be a type of medicine,
prunes are now being thought of as a natural source of anticancer compounds (9).
Although, a few studies have been done on the prune, more are needed to investigate the
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health benefits of the prune, including the possibility of being chemopreventative and
chemotherapeutic.
Of the prunes produced, half will be consumed while the other half will by further
processed (10). An estimation of the daily consumption of the raw plums is 0.89g daily
intake (6). The plum and the black plum account for 50% each of the total plum
consumption (10).
California is the world’s largest producer of dried plums, producing 67% or 178
million kilograms of prunes each year (3).

According to the National Agricultural

Statistics Service, the estimate of the 2010 California dried plum crop production was
150,000 tons. This was a 14% increase from the previous five years average (11). Dried
plums or prunes are made by dehydrating plums at 85-90ºC for 18 hours, so that the
plums can be processed into prunes, prune juice, prune puree, or other prune products.
This process allows dried plums to be stored up to one year due to decreased water
activity of less than 25% and an average of 82mg of ascorbic acid to inhibit molds and
yeasts. The effects of processing a new plum to a dried plum cause many differences in
the chemical composition of the prune. The sugar concentration increases due to the
dehydration and the disappearance of sucrose which has been hydrolyzed into glucose
and fructose instead (12). Processing will degrade half of the phenolic compounds,
flavonols, hydrocinnamic acids, and will completely degrade anthocyanins and flavan-3ols in the dried plum (13).

In addition, a decrease in ascorbic acid, vitamin C,

chlorogenic acid, and neochlorogenic acid will occur after processing raw plums (14). It
has been shown that processing plums into dried plums will cause a 90% decrease in βcarotene, 20% decrease in amino acids, 34% decrease in thiamin, 20% decrease in niacin,
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and a 42% increase in riboflavin (3). However, the processing of prunes into prune juice
will cause a reduction in fiber due to the lack of skin and pulp, but have no effect on the
phenolic compounds (3,13).

Components of a Prune

Basic Nutritive Values and Components
The basic nutritive value for a 100g dried plum consists of 239 calories, 0.52g fat,
62.7g carbohydrates, 2.61g protein, and 7.1g of fiber (15). Prunes are found to be high in
fiber, sorbitol, simple sugars, and phenolic compounds (3). Prunes provide energy due to
their high sugar composition. Fresh prunes can have 12.8-29g of total sugar of which
31% is glucose, 18% fructose, 23%sucrose, and 28% sorbitol (3). Fresh prunes contain
approximately 2.7 g of sorbitol while dried prunes and prune juice contain 15 and 17.8g
of sorbitol per 100g of prune plum (12). Sugar proportions stay similar in fresh, dried,
and juice except for the absence of sucrose in prune juice (12). Prunes contain 616g/100g of fiber. They also contain very little fat. The small amount of fat is due to the
presence of lipids in the prune’s pulp, plum seeds, and in the epicuticular wax that covers
the fruit. Prunes are considered to be a good source of vitamin C, riboflavin, niacin, and
pyridoxine, since they contain greater than 10% of the recommended daily intake. Fresh
prunes contain 5.1-16.5mg vitamin C, while dried prunes contain between 4.0-8.7mg.
They also contain 5% recommended daily intake of vitamin A, because fresh prunes
contain between 0.22-0.57mg of β-carotene, the provitamin A. Total, between 15-30
carotenoids are present. The mineral content on the other hand, usually depends on the
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soil of the region that the fresh prune is grown in. Prunes are considered to be high in
boron with 1.88mg/100g when the requirement for humans is only 1mg/day. Dried
prunes also contain 50mg calcium, 50mg magnesium, and 80mg phosphorus. Prunes also
contain a fair amount of acids, such as 6.9mg salicylic acid to protect from spoilage,
2g/100g organic acids (mostly citric acid), and very few free amino acids (majority are
asparagines) (3).

Phenolic Compounds in Prunes: Neochlorogenic Acid and Chlorogenic Acid
Phenolics are of high abundance in fresh and dried prunes, containing 1.84 mg/g
phenolics in a dried plum (4). There are five times more phenolics in the skin of the
prune than there are in the pulp (3). The total phenolics include caffeoylquinic acids such
as chlorogenic acid and neochlorogenic acid, flavanals such as catechin and procyanidins,
flavanols such as quercitin and its derivatives, and anthocyanins such as cyaniding, 3-Bglucoside, and cyanidine 3-B-rutinoside (8,9). The color of the prune is due to the
presence of anthocyanins, which are water soluble plant pigments responsible for the
blues, purples, and reds present in plants. Fresh plums contain approximately 12.5mg of
anthocyanins (10). However, the odor and flavor of the fresh prune are from volatile
compounds such as B-ionone and nonanal.

Other components of the prune are B-

carboline alkaloids, antioxidants, and cyanogenic glycosides (3). Polyphenolics can vary
depending on the cultivar climate, storage conditions, and processing.

With total

phenolics ranging from 30.8-97.6%, flavanols will account for 1.6-19%, and
anthocyanins will account for 12.6-50.3% (16). It has been shown that prunes are the
highest in antioxidant activity with 204.9-567mg/100g, followed by raisin, blueberry,
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blackberry, strawberry, and raspberry based on oxygen radical absorbance capacity
(ORAC) (16, 5). Of these antioxidants, neochlorogenic acid is the most predominant in
amount, followed by chlorogenic acid (16). For 100g, there are 81mg of neochlorogenic
acid in a fresh prune, 131mg in a dried prune, and 22.5mg in prune juice.

For

chlorogenic acid in 100g, 14.4mg are present in fresh prunes, 44mg present in a dried
prune, and 19.3mg present in prune juice (3).
Phenolics are natural protectants, whose main purpose is to provide an antifungal
defense mechanism in fruit (17). However, phenolics, specifically chlorogenic acid and
neochlorogenic acid, can have protective qualities for humans too. Chlorogenic acid has
weak antimicrobial activity, even to the point of being active against the polio virus at
low concentrations.

Chlorogenic acid also causes dissipation of the sodium

electrochemical gradient so that more glucose will pass through the bowel (3).

Chlorogenic Acid

Neochlorogenic Acid

Figure 1. Chemical structure of chlorogenic acid (3-O-Caffeoylquinic acid, C16H18O9)
and neochlorogenic acid (5-Caffeoylquinic acid, C16H18O9) (18)

Health Effects of Neochlorogenic Acid and Chlorogenic Acid
Role as an Antioxidant
The prune has the highest antioxidant capacity of all dried fruits (8). In fact, the
antioxidant capacity of chlorogenic acid itself is higher than those of vitamin C and
10

vitamin E (5).

Phenolics like chlorogenic acid and neochlorogenic acid exhibit

antioxidative properties by chelating metal ions, inhibiting lipid oxidation, inhibiting
radical forming enzymes, and eliminating free radicals (16). With these properties,
neochlorogenic acid and chlorogenic acid can protect low-density lipoprotein (LDL) from
oxidation by 86-97% so that age-related diseases can be prevented (4).

Role as Chemopreventative/ Chemotherapeutic Agent
Neochlorogenic acid and chlorogenic acid fractions may demonstrate
chemopreventative and chemotherapeutic activities.

They decrease cancer risk by

protecting scavenging reactive oxygen species (ROS), enhancing DNA repair and
carcinogen detoxification, and modifying carcinogen uptake and metabolism. Phenols
target molecular pathways of cancer cells while having a low toxicity in normal cells (9).
From in vivo studies with ileostomy subjects, it has been found that when digested, 33%
of chlorogenic acid is absorbed in the small intestine, and the rest is transported to the
colon, where the bioavailability depends on the metabolism of certain microflora (9). It
has been proven that chlorogenic acid in a person’s diet can inhibit the formation of
tumors in the bowel and liver (3). However, in in-vitro studies, it has also been found
that chlorogenic acid and neochlorogenic acid at concentrations of 17mg/L and 10mg/L
can suppress breast cancer cell growth, MD-MGA-435, while having no effect on normal
breast epithelial cells, MCF-10A (9).
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In-Vitro Studies
There have been numerous studies that have used chlorogenic acid and
neochlorogenic acid at various concentrations, times, and on several carcinoma cell
lines, which have displayed anticarcinogenic behavior.

Table 1 summarizes these

studies.
Table 1. Summary of anticarcinogenic activities of chlorogenic acid and neochlorogenic
acid
Phenolic
Compound
Chlorogenic
Acid;
Neochlorogenic
Acid [9]

Chlorogenic
Acid [19]

Chlorogenic
Acid [20]

Chlorogenic
Acid [21]

Type of
Chlorogenic
Acid: CDCQ
[22]
Chlorogenic
Acid [23]
Chlorogenic
Acid
Derivative: 1,3dicaffeoylmuco-quinic
acid diacetal
[24]

Cell Line

Concentration

Effect

Time

MDA-MB435estrogen
negative
breast cancer
cells

17 mg/L;
10mg/L (IC50)
(47.98µmol/L ;
28.22µmol/L)

Net growth
measured at 3
days

AH109A, rat
ascites
hepatoma
cells
Hep3B,
human liver
carcinoma

0-40µmol/L

Dosedependent
reduction in
cell growth and
viability in
MDA-MB-435
No effect on
proliferation

200-300 µg/ml
(564.5-846.7
µmol/L)

Reduction in
cell growth and
viability

U-87,
glioblastoma
brain-tumor
derived cells
HT-1080,
fibrosarcoma

100µmol/L

Chlorogenic
acid inhibited
growth of U-87
glioma cells
Suppressed
invasion and
migration

HT29, human
colon cancer
Dnmt3a

20µmol/L
(inhibited
invasion by
50%)
289.2 µmol/L
(EC50)
35 µmol/L
(IC50); 0-500
µmol/L
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Killed 50% of
cells
Dosedependent
inhibition of
Dnmt3a
(causes cancer
development)

44hr in
presence of
chlorogenic
acid
24 hours after
incubated with
chlorogenic
acid
18 hours after
incubated with
chlorogenic
acid
24 hours after
incubated with
CDCQ
After 72 hour
treatment
10 minutes
after treated
with
chlorogenic
acid derivative

Phenolic
Compound
Chlorogenic
Acid [25]

Cell Line
HT29, colon
cancer cells;
HepG2 liver
cancer cells

Concentration
0-500 µmol/L
(EC50) HT29;
413µmol/L
HepG2
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Effect
Time and
Dosedependent
reduction in
cell viability
and growth

Time
72 hours after
treatment with
chlorogenic
acid

Chapter III. Materials and Methods
Materials
Chlorogenic acid (CA) and neochlorogenic acid (NCA) were purchased from
Quality Phytochemicals LLC (New Jersey, USA). These compounds were dissolved in
dimethyl sulfoxide (DMSO, ATCC, Rockville, MD) and then added to media at
treatment concentrations of 0, 150, 300, and 500 µmol. The control treatment consisted
of only DMSO and media.

Methods
Cell Culture
Caco-2 cells, a human epithelial colorectal adenocarcinoma (cancer) cell line,
were purchased from the American Type Culture Collection (ATCC, Rockville, MD) at
passage number 18 and cultured in Dulbecco's modified eagle's medium supplemented
with 10% fetal bovine serum (FBS), 1% Non-essential amino acids, and 2% antibioticantimycotic solution.

Cell cultures were maintained under sterile conditions and

incubated at 37°C in a humidified 5% CO2 atmosphere (VWR® symphony™, VWR®
International LLC, Radnor, PA). All media components and reagents were obtained from
Gibco® through Life Technologies (Carlsbad, CA).

Cell Viability Assay
Cells at passage number 22 were used for the proliferation assays. Passage
number refers to the number of times the cell line has been re-plated and allowed to grow
back to confluency (maximum density). The effects of test compounds, chlorogenic acid
14

and neochlorogenic acid, on the cellular proliferation and viability of Caco-2 cells were
measured using the CellTiter 96® AQueous One Solution Cell Proliferation Assay
(Promega Corp. Madison, WI). This assay is a colorimetric method for determining the
number of viable cells in proliferation or cytotoxicity assays. The CellTiter reagent
contains a novel tetrazolium compound and an electron coupling reagent (phenazine
ethosulfate; PES). The tetrazolium compound is reduced by living cells into a colored
formazan product which is soluble in culture medium. The quantity of this product,
measured at absorbance of 490nm by a plate reader, is directly proportional to the
number of living cells in the culture.
To perform this assay, (3 x 103) Caco-2 cells in 100µl of Dulbeco’s modified
Eagles medium (DMEM) media containing 10% fetal bovine serum were seeded in the
wells of a 96 well plate and incubated at 37°C and 5% CO2. Cells were incubated for 24
hours to allow stable attachment before exposure to test compounds. The used media
was removed and replaced with test media containing chlorogenic acid and
neochlorogenic acid at treatment concentrations of 0, 150, 300, and 500 µmol designated
as time point 0.
Viability measurements were made at 0, 24, 48, and 72 hours after the addition of
treatment. This was accomplished by adding 20µl of CellTiter reagent directly to the
treatment wells containing cells and wells containing only the test media (sample
control). A negative control was used to measure the viability of Caco-2 cells in the
absence of test compounds.

Experiments were conducted using quadruplicate

determinations for each concentration for a test compound per plate. Microplates were
incubated for 4 hours after the addition of the reagent, before measuring the absorbance
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at 490nm with the plate reader (Synergy HT Multi-Mode Microplate Reader, BioTek
Instruments, Inc., Winooski, VT).

After all absorbance readings were made, data was

corrected for the background absorbance of the control media as well as the sample
control media which contained chlorogenic acid or neochlorogenic acid but no cells.
Absorbances were then converted into cell numbers using an equation from the Caco-2
cell standard curve completed earlier in which a serial dilution of cells was prepared in
triplicate in a 96 well plate which ranged from 350 cells per ml to 70,000 cells per ml
(Figure 1.). This was accomplished by seeding cells as in the actual experiment, adding
CellTiter reagent directly to wells, and then measuring the absorbances of these cells.
The results were plotted to compare the change in absorbance as the total cell number
increased. From this standard curve, an equation of y=29676.18x with an R2 value of
0.99 was obtained. Calculated cell numbers were then used to plot cell growth curves.
Light Microscopy of Cells
Cell morphology was observed using a Nikon Eclipse E400 light microscope with
Nikon Camera Head DS-Fi1. Cells were used to visualize and describe morphology
changes. After 24 and 48 hours of treatment with chlorogenic acid and neochlorogenic
acid, cells were harvested and an aliquot was taken from the cell suspension. A portion
of the aliquot was then stained with trypan blue dye to provide contrast and determine
viable from non-viable cells. 10µl of the aliquot was then pipetted onto a slide and
covered with a cover-slip.

The prepared slides were viewed under low power

magnification until an acceptable viable cell was identified. All viable cells located on
the slide were examined, after which the most representative cell with the clearest image
was chosen. The cell of interest was then viewed under higher power (400x). Using the
16

Nikon camera software, contrast and color was adjusted to provide the best possible
image, after which, a still shot was taken and saved for later viewing.
Statistical Analysis
Data were analyzed using Statistical Analysis System (Version 9.2; SAS Institute
Inc., Cary, NC). Results were analyzed using one-way analysis of variance with an alpha
level of 0.05, followed by Fisher’s least significant difference (LSD) test. Data was
presented as means ± standard error of the mean (SEM).
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Chapter IV. Results
Neochlorogenic Acid and Chlorogenic Acid Inhibit Proliferation of Caco-2 Cells
Treatment of Caco-2 cell line with both chlorogenic acid and neochlorogenic acid
resulted in a significant reduction in cell proliferation in comparison to the untreated
control (Table 2, Figure 3. (a) & (b)). At 24 hours, all treatments and concentrations
(150, 300, 500 µmol) significantly decreased the viable cell number compared to the
control.

At concentrations of 150, 300, and 500µmol, the number of living cells

decreased by 63.7, 90.1, and 85.7% for chlorogenic acid and 69.7, 90.2, and 85.7% for
neochlorogenic acid respectively compared to the control (Figure 3. (a) & (b)). At 48
hours, chlorogenic and neochlorogenic acid decreased viable cell numbers by 66.1, 94.7,
and 92.3% for chlorogenic acid and 33.1, 91.9, and 90.7% for neochlorogenic acid
(Figure 3. (a) & (b)). After the final time point of 72 hours, viable cell numbers were
reduced by 56.0, 92.2, and 96.0% for chlorogenic acid and 63.8, 92.8, and 94.2 for
neochlorogenic acid (Figure 3. (a) & (b)). The 300 and 500µmol concentrations for both
chlorogenic acid and neochlorogenic acid were the most effective for suppressing cell
growth and maintaining the inhibitory effect, being significantly different from the
150µmol concentration. The effectiveness of reduced cell proliferation was strongly
correlated with the increasing concentration of the treatment.
Light Microscopy of Cells
Figure 3 shows the cell morphology observations of Caco-2 cells treated with
chlorogenic acid (Figure 4. (b) & (d)) and neochlorogenic acid (Figure 4. (c) & (e)) at
concentrations of 150, 300, and 500µmol. Figure 4. (b) & (c) represents Caco-2 cells at
24 hours and Figure 3. (d) & (e) represents Caco-2 cells at 48 hours. It can be seen in all
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of the isolated cell images that the Caco-2 cell surfaces become more rough, uneven, and
irregularly-shaped as the treatment time and concentration increased.
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Chapter V. Discussion
The prune is an important source of polyphenols in the United States. Prunes
have the highest antioxidant activity of all fruits, of which neochlorogenic acid is the
most dominant followed by chlorogenic acid (16). There are many health benefits
associated with the consumption of the prune, including chemopreventative and
chemotherapeutic properties (3).

The phenolic compounds in the prune have been

suspected for these health-promoting activities, but there is little research to confirm this
matter. There have been numerous in-vitro studies testing the antiproliferative behavior
of chlorogenic acid, yet there is little consistency between studies (9, 19, 20, 21, 22, 23,
24, 25). Numerous cell lines, concentrations of treatment, length of study, and methods
used have been explored, and therefore various results have been concluded. Also, there
has been little to no research on neochlorogenic acid as a phenolic compound with
anticarcinogenic properties
Of all the theories for the anticarcinogenic action by the prune, there are many
studies that have investigated phenolic compounds for their inhibitory effect on cancer
cells. The present study investigated this hypothesis by evaluating the effects of the main
phenolic compounds found in the prune, neochlorogenic acid and chlorogenic acid, on
cell proliferation and morphology of Caco-2 human colon cancer cells. It was found that
neochlorogenic acid and chlorogenic acid significantly inhibited the growth and viability
of Caco-2 cells in a concentration-dependent manner compared to the untreated control.
Treatment with chlorogenic acid and neochlorogenic acid visibly altered the cell
morphology of viable human colon cancer cells as well.
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Results found corresponded most with studies by Veeriah et al. (23) and Glei et al.
(25). Both studies utilized the HT29, human colon adenocarcinoma cell line with a
doubling time of approximately 25 hours (26). In both studies, it was found that only the
highest concentrations of 500µmol/L (25) and 289.2µmol/L (23) of chlorogenic acid were
able to achieve a 50% cell survival number (EC50) after 72 hours of treatment. Studies
seeded cells in 96-well microtiter plates, allowed to attach for 24 and 48 hours (25, 23),
incubated cells for 24, 48, and 72 hours, added 4’6’-diamino-2-pheynlindole
dihydrochloride (DAPI) DNA dye and then measured the percentage of surviving cells by
fluorimetric analysis at 360 and 465nm with a 96-well microtiter plate reader. The
present study differed only in cell line and the assay used to measure the surviving cells.
Despite the common type of cell line, chlorogenic acid appeared to be more effective in
reducing the cell number in Caco-2 cells compared to HT29 cells. Even at the lowest
concentration of 150µmol, both chlorogenic acid and neochlorogenic acid were able to
reduce cell growth by 63.7% and 69.7% respectively in as short as 24 hours.
Other in-vitro studies that measured cell proliferation found dose-dependent
reduction in cell growth at high enough concentrations (9, 19, 20, 21). However, it is
important to recognize that these studies used different methods and cell lines that were
not derived from the colon. There was only one study (9) found on the effects of
neochlorogenic acid on cell proliferation compared to chlorogenic acid.

This in vitro

study tested the effects of neochlorogenic acid and chlorogenic acid on cell proliferation
in an estrogen receptor negative MDA-MB-435 breast cancer cell line (9). Net growth of
cells compared to control was reduced by 50% at concentrations of 17 and 10mg/L
(47.98 and 28.22µmol/L) for chlorogenic acid and neochlorogenic acid at 72 hours (9).
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Noratto et al. suggests that neochlorogenic acid may be a more potent bioactive
compound against metastatic cancer than chlorogenic acid (9). Although this may have
been the case for the MDA-MB-435 breast cancer cell line, there were no significant
differences in percent reduction of cell number between chlorogenic acid and
neochlorogenic acid in most concentrations and time points in the present study with
Caco-2 human colon cancer cell line. Based on other in vitro studies, the concentration
of chlorogenic acid needed to inhibit cell growth varied with the type of cell line used.
Jin et al. (20) tested the effects of chlorogenic acid on Hep3B human liver carcinoma cell
line and saw only a 12% reduction in cells at concentrations of 200µg/ml (564.5µmol/L)
and above at 24 hours. Compared to the Caco-2 colon adenocarcinoma cell line, liver
carcinoma was much less sensitive to chlorogenic acid and required a larger
concentration for a lesser cell reduction effect. An in vitro study with chlorogenic acid
on cell proliferation of U-87 human brain glioblastoma required only 100µmol/L for
approximately a 70% reduction of cells in 18 hours (21). The brain glioblastoma cell line
was similar to colon adenocarcinoma, with a larger reduction of cell growth with a
smaller concentration of chlorogenic acid. A similar study required only 20µmol/L of
chlorogenic to suppress HT-1080 human connective tissue fibrosarcoma by 50% in
24hours (22). Human connective tissue fibrosarcoma proved to be much more sensitive
that all other cell lines, with the smallest concentration to provide a significant reduction
in cell growth.
In the present study, there was significant inhibition of Caco-2 cell viability
compared to the control cells for all concentrations of chlorogenic acid and
neochlorogenic acid and time points.

There was no significant difference in cell
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reduction among the chlorogenic acid and neochlorogenic acid treatments at all
concentrations and time points, with the exception of the 150µmol treatment at 48 hours.
The 150µmol concentration was the least effective, having a significantly smaller
reduction in cell growth compared to the higher concentration treatments and failing to
maintain inhibition. Cell growth did rebound at 48 hours for chlorogenic acid and 24
hours for neochlorogenic acid at 150µmol. It can be hypothesized that this observation
may be due to mitohormesis, the phenomenon of increased net cell growth in the
presence of low doses of a compound that inhibits cell proliferation.

A low dosage of

the inhibitor can actually trigger repair mechanisms in the cell, which can neutralize the
effect of this compound as well as repair other non-toxin related effects and therefore
increase cell growth (9). In this study, mitohormesis would have occurred after 48 hours
in the chlorogenic acid treatment and after 24 hours in the neochlorogenic acid treatment.
The higher concentration treatments were significantly higher in cell reduction than the
150µmol concentration, yet were not significantly different from one another (Table 2).
Although, the 300µmol treatment was observed to be more efficient at reducing the Caco2 cell number through 48 hours compared to the 500µmol treatment, the difference was
not significant. The 500µmol treatments were the most effective, with a time-dependent
reduction in cell proliferation and the highest cell viability reduction of 96% for
chlorogenic acid and 94.2% for neochlorogenic acid at 72 hours.
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Chapter VI. Conclusion
In conclusion, it has been observed in this study that treatment of Caco-2 human
adenocarcinoma cells with phenolic compounds from the prune strongly inhibited cell
proliferation and changed the morphology of the cells. Only at the higher concentrations
of 300 and 500µmol, was the inhibitory effect of cell proliferation able to be maintained
in a time-dependent manner. The findings from this study suggest that chlorogenic acid
and neochlorogenic acid may be colon-cancer suppressive components of the prune.
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Appendix
Figure 2. CellTiter 96® AQueous One Solution Caco-2 cell standard curve
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Figure 3. (a) Chlorogenic acid effects on CaCo-2 cell proliferation
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Negative Control
CA 150 µmol
CA 300 µmol
CA 500 µmol

No. of Cells x 1,000

18

13

*
8

3

-3

0

*

*
*
*
24

*
*
48

*
*

72

Time (hours)

Different concentrations of Chlorogenic Acid (CA) at each incubation time were
compared against the negative control using Dunnett’s test. Points marked with (*)
represent significant differences from the control (p <0.05).
(b) Neochlorogenic acid effects on Caco-2 cell proliferation
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Negative Control

No. of Cells x 1,000

18

NCA 150 µmol
NCA 300 µmol
13

NCA 500 µmol

8

3

-3

0

*
*
*
24

*

*

*
*
48

*
*

72

Time (hours)

Different concentrations of Neochlorogenic Acid (NCA) at each incubation time were
compared against the negative control using Dunnett’s test. Points marked with (*)
represent significant differences from the control (p < 0.05).
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3.99
0.68
0.64
2.88
1.46
1.85

63.7a
90.1b
85.7b
69.7a
90.2b
85.7b

300
500

300
500

150

150

SEM

Percent
Reduction

Conc.
(µmol)

90.7c

91.9c

33.1a

92.3c

94.7c

66.1b

Percent
Reduction

48 Hours

0.61

0.19

4.14

1.03

0.72

6.00

SEM

94.2b

92.8b

63.8a

96.0b

92.2b

56.0a

Percent
Reduction

72 hours

0.37

0.84

5.67

0.17

0.20

3.73

SEM
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Data represents the percent reduction (%) compared with negative control and the standard error of the mean (SEM) (n = 3). Values in
a column without common superscripts are significantly different (p < 0.05).

Neochlorogenic Acid

Chlorogenic Acid

Treatment

24 Hours

Table 2. Chlorogenic and neochlorogenic acid percent reduction in cell viability

Figure 4. Morphology effects of treatments with different concentrations of
chlorogenic acid and neochlorogenic acid
(a) Untreated Caco-2 cell

(b) Chlorogenic acid treatment for 24 hours

(i)

150
µmol

(ii) 300 µmol

(iii) 500 µmol

(c) Neochlorogenic acid treatment for 24 hours

(i)

150
µmol

(ii) 300 µmol
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(iii) 500 µmol

(d) Chlorogenic acid treatment for 48 hours

(i)

150
µmol

(ii) 300 µmol

(iii) 500 µmol

(e) Neochlorogenic acid treatment for 48 hours

(i)

150
µmol

(ii) 300 µmol
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(iii) 500 µmol
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